Yunjie Wang

Dr. Yunjie Wang


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2019 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
QLQiang Liu
Qiang Liu
YGYanlei Guan
Yanlei Guan
ZLZhenhang Li
Zhenhang Li
YWYao Wang
Yao Wang
YLYu Liu
Yu Liu
YWYunjie Wang
Yunjie Wang
MicroRNAs (miRNAs) play crucial roles in tumor initiation and development. Previously, we indicated that miR-504 is downregulated and suppresses tumor proliferation in glioblastoma (GBM). However, the regulation and relevant mechanism of miR-504 in GBM mesenchymal (ME) transition remain unclear. Transcriptome and clinical data were obtained from The Cancer Genome Atlas (TCGA) database. The potential functions of miR-504 were predicted using gene ontology analysis. GBM cell migration and invasion were examined using wound healing and Transwell assays. Epithelial–mesenchymal transition (EMT) progression in GBM cell lines was detected with immunofluorescence and western blotting. The stemness activity of glioma stem-like cells (GSCs) was assessed by sphere formation assay and tumor xenograft model. miR-504 binding to the FZD7 (frizzled class receptor 7) 3′ untranslated region (3′UTR) was validated using dual luciferase reporter assay. TOP/FOP Flash assays were conducted to determine the effects of miR-504 on Wnt/β-catenin signaling. Analysis of TCGA transcriptomic data showed that low miR-504 expression correlated with ME subtype transition and poor survival in patients with GBM. Functional experiments showed that miR-504 overexpression suppressed malignant behaviors of GBM cells, such as migration, invasion, EMT, and stemness activity. Furthermore, miR-504 was a negative regulator of the Wnt–β-catenin pathway by directly repressing FZD7 expression, and FZD7 overexpression reversed the EMT inhibition caused by miR-504. Moreover, the low miR-504/FZD7 expression ratio was a ME subtype marker and could serve as a significant prognostic indicator and predict the clinical outcome of chemotherapy and radiotherapy for patients with GBM in TCGA dataset. Our results suggest that miR-504 suppresses the aggressive biological processes associated with the ME phenotype of GBM and could be a potential candidate for therapeutic applications in these malignant brain tumors.

1 April 2016 in Cancer Letters
Verified
Journal Article
Closed access
RCRun Cui
Run Cui
YGYanlei Guan
Yanlei Guan
CSChuanqi Sun
Chuanqi Sun
LCLing Chen
Ling Chen
YBYijun Bao
Yijun Bao
YWYunjie Wang
Yunjie Wang

1 June 2015
Verified
Journal Article
Closed access
YGYanlei Guan
Yanlei Guan
LCLing Chen
Ling Chen
YBYijun Bao
Yijun Bao
BQBo Qiu
Bo Qiu
CPChao Pang
Chao Pang
YWYunjie Wang
Yunjie Wang

1 May 2015
Verified
Journal Article
Closed access
CPChao Pang
Chao Pang
YGYanlei Guan
Yanlei Guan
KZKai Zhao
Kai Zhao
LCLing Chen
Ling Chen
YBYijun Bao
Yijun Bao
YWYunjie Wang
Yunjie Wang

15 July 2015
Verified
Journal Article
Closed access
YGYanlei Guan
Yanlei Guan
LCLing Chen
Ling Chen
YBYijun Bao
Yijun Bao
ZLZhipeng Li
Zhipeng Li
RCRun Cui
Run Cui
YWYunjie Wang
Yunjie Wang

2 May 2017 in Cell Biology International
Verified
Journal Article
Closed access
DZDongyong Zhang
Dongyong Zhang
BQBo Qiu
Bo Qiu
YWYunjie Wang
Yunjie Wang
YGYanlei Guan
Yanlei Guan
LZLuyang Zhang
Luyang Zhang
AWAnhua Wu
Anhua Wu